{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T23:19:53Z","timestamp":1791587993599,"version":"4.3.4"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,12,13]],"date-time":"2026-12-13T00:00:00Z","timestamp":1797120000000},"content-version":"am","delay-in-days":287,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U01NS113388"],"award-info":[{"award-number":["U01NS113388"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U01NS113445"],"award-info":[{"award-number":["U01NS113445"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U01NS113451"],"award-info":[{"award-number":["U01NS113451"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U24NS113452"],"award-info":[{"award-number":["U24NS113452"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006034","name":"University of Southern California","doi-asserted-by":"publisher","award":["U24NS113452"],"award-info":[{"award-number":["U24NS113452"]}],"id":[{"id":"10.13039\/100006034","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005326","name":"Yale University","doi-asserted-by":"publisher","award":["U01NS113445"],"award-info":[{"award-number":["U01NS113445"]}],"id":[{"id":"10.13039\/100005326","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008893","name":"University of Iowa","doi-asserted-by":"publisher","award":["U01NS113388"],"award-info":[{"award-number":["U01NS113388"]}],"id":[{"id":"10.13039\/100008893","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008893","name":"University of Iowa","doi-asserted-by":"publisher","award":["R35HL139926"],"award-info":[{"award-number":["R35HL139926"]}],"id":[{"id":"10.13039\/100008893","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007880","name":"Johns Hopkins University","doi-asserted-by":"publisher","award":["R01NS105894"],"award-info":[{"award-number":["R01NS105894"]}],"id":[{"id":"10.13039\/100007880","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007880","name":"Johns Hopkins University","doi-asserted-by":"publisher","award":["R01NS102583"],"award-info":[{"award-number":["R01NS102583"]}],"id":[{"id":"10.13039\/100007880","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005294","name":"Massachusetts General Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005294","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012127","name":"Augusta University","doi-asserted-by":"publisher","award":["RF1NS122863"],"award-info":[{"award-number":["RF1NS122863"]}],"id":[{"id":"10.13039\/100012127","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012127","name":"Augusta University","doi-asserted-by":"publisher","award":["U01NS113356"],"award-info":[{"award-number":["U01NS113356"]}],"id":[{"id":"10.13039\/100012127","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.neuropharm.2025.110801","type":"journal-article","created":{"date-parts":[[2025,12,6]],"date-time":"2025-12-06T00:07:16Z","timestamp":1764979636000},"page":"110801","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Evaluating tocilizumab in ischemic stroke: Findings from the SPAN multicenter trial"],"prefix":"10.1016","volume":"285","author":[{"given":"Anjali","family":"Chauhan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9440-9119","authenticated-orcid":false,"given":"Eunyoung Angela","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9727-9738","authenticated-orcid":false,"given":"Rakesh B.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2477-3011","authenticated-orcid":false,"given":"Mariia","family":"Kumskova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrique C.","family":"Leira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anil K.","family":"Chauhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanrong","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suyi","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymond C.","family":"Koehler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krishnan M.","family":"Dhandapani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Badruzzaman","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pradip K.","family":"Kamat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2902-3671","authenticated-orcid":false,"given":"Ali","family":"Arbab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David C.","family":"Hess","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alison L.","family":"Herman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ligia","family":"Boisserand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren H.","family":"Sansing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreia","family":"Morais","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuyan","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanem","family":"Aykan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiko","family":"Imai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cenk","family":"Ayata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7300-9968","authenticated-orcid":false,"given":"Karisma A.","family":"Nagarkatti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Lamb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2427-7843","authenticated-orcid":false,"given":"M\u00e1rcio A.","family":"Diniz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick D.","family":"Lyden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louise D.","family":"McCullough","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaroslaw","family":"Aronowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"15","key":"10.1016\/j.neuropharm.2025.110801_bib1","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1016\/j.jacc.2021.02.049","article-title":"Randomized trial of Interleukin-6 receptor inhibition in patients with acute ST-Segment elevation myocardial infarction","volume":"77","author":"Broch","year":"2021","journal-title":"J. Am. Coll. Cardiol."},{"issue":"12","key":"10.1016\/j.neuropharm.2025.110801_bib2","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1177\/0271678X18793324","article-title":"Sex differences in stroke: challenges and opportunities","volume":"38","author":"Bushnell","year":"2018","journal-title":"J. Cerebr. Blood Flow Metabol."},{"key":"10.1016\/j.neuropharm.2025.110801_bib3","series-title":"IEEE Intl. Symposium on Biomedical Imaging (ISBI)","article-title":"Computational image-based stroke assessment for evaluation of cerebroprotectants with longitudinal and multi-site preclinical MRI","author":"Cabeen","year":"2023"},{"key":"10.1016\/j.neuropharm.2025.110801_bib45","series-title":"(11th European Stroke Organisation Conference Abstracts \u2013 21-23 May 2025, Helsinki, Finland: Late Breaking Abstracts) EFFECT OF INTERLEUKIN-6 RECEPTOR INHIBITION IN PATIENTS WITH ISCHEMIC STROKE UNDERGOING ENDOVASCULAR TREATMENT (IRIS)","author":"Chu","year":"2025"},{"issue":"Pt B","key":"10.1016\/j.neuropharm.2025.110801_bib4","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1016\/j.neuroimage.2015.04.067","article-title":"The image and data archive at the laboratory of neuro imaging","volume":"124","author":"Crawford","year":"2016","journal-title":"Neuroimage"},{"issue":"2","key":"10.1016\/j.neuropharm.2025.110801_bib5","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1590\/1414-431X20122472","article-title":"The chronic blockade of angiotensin I-converting enzyme eliminates the sex differences of serum cytokine levels of spontaneously hypertensive rats","volume":"46","author":"Dalpiaz","year":"2013","journal-title":"Braz. J. Med. Biol. Res."},{"key":"10.1016\/j.neuropharm.2025.110801_bib6","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/978-1-4939-7568-6_11","article-title":"Dissecting Interleukin-6 Classic- and trans-signaling in inflammation and cancer","volume":"1725","author":"Garbers","year":"2018","journal-title":"Methods Mol. Biol."},{"issue":"3","key":"10.1016\/j.neuropharm.2025.110801_bib8","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCGEN.119.002872","article-title":"Interleukin-6 signaling effects on ischemic stroke and other cardiovascular outcomes: a mendelian randomization study","volume":"13","author":"Georgakis","year":"2020","journal-title":"Circ Genom Precis Med"},{"issue":"Pt 6","key":"10.1016\/j.neuropharm.2025.110801_bib9","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1093\/brain\/aws075","article-title":"Essential role of interleukin-6 in post-stroke angiogenesis","volume":"135","author":"Gertz","year":"2012","journal-title":"Brain"},{"issue":"6","key":"10.1016\/j.neuropharm.2025.110801_bib10","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1038\/s41591-025-03635-5","article-title":"CONSORT 2025 statement: updated guideline for reporting randomized trials","volume":"31","author":"Hopewell","year":"2025","journal-title":"Nat. Med."},{"key":"10.1016\/j.neuropharm.2025.110801_bib11","doi-asserted-by":"crossref","first-page":"83","DOI":"10.3389\/fneur.2019.00083","article-title":"IL-6 plasma levels correlate with cerebral perfusion deficits and infarct sizes in stroke patients without associated infections","volume":"10","author":"Hotter","year":"2019","journal-title":"Front. Neurol."},{"issue":"3","key":"10.1016\/j.neuropharm.2025.110801_bib12","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.bja.2017.11.096","article-title":"Interleukin-6 is both necessary and sufficient to produce perioperative neurocognitive disorder in mice","volume":"120","author":"Hu","year":"2018","journal-title":"Br. J. Anaesth."},{"key":"10.1016\/j.neuropharm.2025.110801_bib13","series-title":"International Stroke Conference","article-title":"Amelioration of ischemic stroke damage through inhibition of interleukin-6 signaling with tocilizumab requires sex specific dosing","author":"Hudobenko","year":"2019"},{"key":"10.1016\/j.neuropharm.2025.110801_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2022.104013","article-title":"Interleukin-6 inhibition in ST-elevation myocardial infarction: immune cell profile in the randomised ASSAIL-MI trial","volume":"80","author":"Huse","year":"2022","journal-title":"EBioMedicine"},{"issue":"20","key":"10.1016\/j.neuropharm.2025.110801_bib15","doi-asserted-by":"crossref","first-page":"e2375","DOI":"10.1212\/WNL.0000000000007416","article-title":"Inflammatory cytokines and ischemic stroke risk: the REGARDS cohort","volume":"92","author":"Jenny","year":"2019","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.neuropharm.2025.110801_bib16","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.joca.2018.10.010","article-title":"IL6 receptor blockade preserves articular cartilage and increases bone volume following ischemic osteonecrosis in immature mice","volume":"27","author":"Kamiya","year":"2019","journal-title":"Osteoarthr. Cartil."},{"issue":"3","key":"10.1016\/j.neuropharm.2025.110801_bib17","doi-asserted-by":"crossref","first-page":"H935","DOI":"10.1152\/ajpheart.00708.2005","article-title":"Angiotensin II hypertension is attenuated in interleukin-6 knockout mice","volume":"290","author":"Lee","year":"2006","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"4","key":"10.1016\/j.neuropharm.2025.110801_bib18","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1007\/s13311-020-00893-8","article-title":"IL-6 receptor blockade by tocilizumab has anti-absence and anti-epileptogenic effects in the WAG\/Rij rat model of absence epilepsy","volume":"17","author":"Leo","year":"2020","journal-title":"Neurotherapeutics"},{"issue":"2","key":"10.1016\/j.neuropharm.2025.110801_bib19","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1097\/00004647-199802000-00008","article-title":"Cerebral interleukin-6 is neuroprotective during permanent focal cerebral ischemia in the rat","volume":"18","author":"Loddick","year":"1998","journal-title":"J. Cerebr. Blood Flow Metabol."},{"issue":"5","key":"10.1016\/j.neuropharm.2025.110801_bib20","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0232612","article-title":"Tocilizumab does not block interleukin-6 (IL-6) signaling in murine cells","volume":"15","author":"Lokau","year":"2020","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.neuropharm.2025.110801_bib21","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1161\/STROKEAHA.121.038047","article-title":"The stroke preclinical assessment network: rationale, design, feasibility, and stage 1 results","volume":"53","author":"Lyden","year":"2022","journal-title":"Stroke"},{"issue":"714","key":"10.1016\/j.neuropharm.2025.110801_bib22","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.adg8656","article-title":"A multi-laboratory preclinical trial in rodents to assess treatment candidates for acute ischemic stroke","volume":"15","author":"Lyden","year":"2023","journal-title":"Sci. Transl. Med."},{"issue":"2","key":"10.1016\/j.neuropharm.2025.110801_bib23","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1097\/MAJ.0b013e3181c6a968","article-title":"Circulating endothelial progenitor cells, Th1\/Th2\/Th17-related cytokines, and endothelial dysfunction in resistant hypertension","volume":"339","author":"Magen","year":"2010","journal-title":"Am. J. Med. Sci."},{"issue":"8","key":"10.1016\/j.neuropharm.2025.110801_bib24","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1016\/j.bbi.2011.06.015","article-title":"Functional recovery in aging mice after experimental stroke","volume":"25","author":"Manwani","year":"2011","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.neuropharm.2025.110801_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.resuscitation.2022.109676","article-title":"Modulation of inflammation by treatment with tocilizumab after out-of-hospital cardiac arrest and associations with clinical status, myocardial- and brain injury","volume":"184","author":"Meyer","year":"2023","journal-title":"Resuscitation"},{"issue":"19","key":"10.1016\/j.neuropharm.2025.110801_bib26","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1161\/CIRCULATIONAHA.120.053318","article-title":"Treatment effects of Interleukin-6 receptor antibodies for modulating the systemic inflammatory response after out-of-hospital cardiac arrest (the IMICA trial): a double-blinded, placebo-controlled, single-center, randomized, clinical trial","volume":"143","author":"Meyer","year":"2021","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.neuropharm.2025.110801_bib27","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1111\/cns.14041","article-title":"Contemplating IL-6, a double-edged sword cytokine: which side to use for stroke pathology?","volume":"29","author":"Monsour","year":"2023","journal-title":"CNS Neurosci. Ther."},{"issue":"4","key":"10.1016\/j.neuropharm.2025.110801_bib28","doi-asserted-by":"crossref","first-page":"C554","DOI":"10.1152\/ajpcell.00323.2020","article-title":"Overlapping and distinct biological effects of IL-6 classic and trans-signaling in vascular endothelial cells","volume":"320","author":"Montgomery","year":"2021","journal-title":"Am. J. Physiol. Cell Physiol."},{"issue":"5","key":"10.1016\/j.neuropharm.2025.110801_bib29","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1080\/17512433.2022.2097905","article-title":"Current status and prospects of IL-6-targeting therapy","volume":"15","author":"Narazaki","year":"2022","journal-title":"Expet Rev. Clin. Pharmacol."},{"issue":"6","key":"10.1016\/j.neuropharm.2025.110801_bib30","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1182\/blood-2018-05-846428","article-title":"Improved CNS exposure to tocilizumab after cerebrospinal fluid compared to intravenous administration in rhesus macaques","volume":"132","author":"Nellan","year":"2018","journal-title":"Blood"},{"issue":"Suppl. 1","key":"10.1016\/j.neuropharm.2025.110801_bib31","doi-asserted-by":"crossref","first-page":"i21","DOI":"10.1136\/ard.59.suppl_1.i21","article-title":"Anti-interleukin 6 receptor antibody treatment in rheumatic disease","volume":"59","author":"Nishimoto","year":"2000","journal-title":"Ann. Rheum. Dis."},{"issue":"3","key":"10.1016\/j.neuropharm.2025.110801_bib32","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S0165-2478(02)00202-X","article-title":"Characterization of anti-mouse interleukin-6 receptor antibody","volume":"84","author":"Okazaki","year":"2002","journal-title":"Immunol. Lett."},{"issue":"6","key":"10.1016\/j.neuropharm.2025.110801_bib33","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.96244","article-title":"Deficiency of immunoregulatory indoleamine 2,3-dioxygenase 1in juvenile diabetes","volume":"3","author":"Orabona","year":"2018","journal-title":"JCI Insight"},{"issue":"10","key":"10.1016\/j.neuropharm.2025.110801_bib34","doi-asserted-by":"crossref","first-page":"e1002","DOI":"10.1212\/WNL.0000000000013274","article-title":"Circulating Interleukin-6 levels and incident ischemic stroke: a systematic review and meta-analysis of prospective studies","volume":"98","author":"Papadopoulos","year":"2022","journal-title":"Neurology"},{"key":"10.1016\/j.neuropharm.2025.110801_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.ceca.2021.102358","article-title":"The aging mouse brain: cognition, connectivity and calcium","volume":"94","author":"Radulescu","year":"2021","journal-title":"Cell Calcium"},{"issue":"1","key":"10.1016\/j.neuropharm.2025.110801_bib36","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s12964-019-0356-0","article-title":"Response to IL-6 trans- and IL-6 classic signalling is determined by the ratio of the IL-6 receptor alpha to gp130 expression: fusing experimental insights and dynamic modelling","volume":"17","author":"Reeh","year":"2019","journal-title":"Cell Commun. Signal."},{"issue":"5","key":"10.1016\/j.neuropharm.2025.110801_bib37","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/j.bbamcr.2011.01.034","article-title":"The pro- and anti-inflammatory properties of the cytokine interleukin-6","volume":"1813","author":"Scheller","year":"2011","journal-title":"Biochim. Biophys. Acta"},{"issue":"3","key":"10.1016\/j.neuropharm.2025.110801_bib38","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1038\/jcbfm.2008.141","article-title":"Ambivalent aspects of interleukin-6 in cerebral ischemia: inflammatory versus neurotrophic aspects","volume":"29","author":"Suzuki","year":"2009","journal-title":"J. Cerebr. Blood Flow Metabol."},{"issue":"4","key":"10.1016\/j.neuropharm.2025.110801_bib39","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1111\/j.1467-9868.2011.01020.x","article-title":"Probabilistic index models","volume":"74","author":"Thas","year":"2012","journal-title":"J. Roy. Stat. Soc. B Stat. Methodol."},{"issue":"4","key":"10.1016\/j.neuropharm.2025.110801_bib40","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.chom.2017.03.002","article-title":"Age-associated microbial dysbiosis promotes intestinal permeability, systemic inflammation, and macrophage dysfunction","volume":"21","author":"Thevaranjan","year":"2017","journal-title":"Cell Host Microbe"},{"issue":"3","key":"10.1016\/j.neuropharm.2025.110801_bib41","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1161\/HYPERTENSIONAHA.114.03512","article-title":"Female spontaneously hypertensive rats have a compensatory increase in renal regulatory T cells in response to elevations in blood pressure","volume":"64","author":"Tipton","year":"2014","journal-title":"Hypertension"},{"issue":"2","key":"10.1016\/j.neuropharm.2025.110801_bib42","first-page":"145","article-title":"Tocilizumab inhibits neuronal cell apoptosis and activates STAT3 in cerebral infarction rat model","volume":"16","author":"Wang","year":"2016","journal-title":"Bosn. J. Basic Med. Sci."},{"issue":"1","key":"10.1016\/j.neuropharm.2025.110801_bib43","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1161\/STROKEAHA.110.588954","article-title":"Association of circulating inflammatory markers with recurrent vascular events after stroke: a prospective cohort study","volume":"42","author":"Whiteley","year":"2011","journal-title":"Stroke"},{"key":"10.1016\/j.neuropharm.2025.110801_bib44","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.metabol.2018.01.002","article-title":"IL-6 receptor blockade ameliorates diabetic nephropathy via inhibiting inflammasome in mice","volume":"83","author":"Wu","year":"2018","journal-title":"Metabolism"},{"issue":"3","key":"10.1016\/j.neuropharm.2025.110801_bib46","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1158\/0008-5472.CAN-06-3641","article-title":"Establishment of a new interleukin-6 (IL-6) receptor inhibitor applicable to the gene therapy for IL-6-dependent tumor","volume":"67","author":"Yoshio-Hoshino","year":"2007","journal-title":"Cancer Res."},{"key":"10.1016\/j.neuropharm.2025.110801_bib47","article-title":"Interleukins and ischemic stroke","volume":"13","author":"Zhu","year":"2022","journal-title":"Front. Immunol."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002839082500509X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002839082500509X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T08:30:24Z","timestamp":1781771424000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002839082500509X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":46,"alternative-id":["S002839082500509X"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2025.110801","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluating tocilizumab in ischemic stroke: Findings from the SPAN multicenter trial","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2025.110801","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"110801"}}